Navigation Links
HealthSaaS Inc. with iMPak Health and Meridian Health Announce Integrated Pain Management and Medication Adherence Solution
Date:1/10/2012

PORTLAND, Ore. and NEPTUNE, N.J., Jan. 11, 2012 /PRNewswire-iReach/ -- The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.  The Health Journal for Pain provides a consumer engaged method for date and time stamp pain levels and the impact of both long-acting and short medications not readily seen before.

About the size of a smart phone or credit card, iMPak Health products are daily journal device cards that capture health-related data and transmit the information wirelessly using a Near Field Communications (NFC) reader.

Using the HealthSaaS Connected Outcomes Platform patient data will be securely transmitted from a patient's home to health care providers. Physician-requested data can be viewed within graphical reports using HealthSaaS white-labeled provider portals and optionally into backend Electronic Health Record systems (EHRs). Data can also be viewed by patients, family members and caregivers using HealthSaaS patient portals.

"It is widely held that pain is considered the fifth vital sign. The pain journal not only helps track daily pain levels, but is a easy and powerful tool for determining a specific patient's response to their medication regimen," said Sandra Elliott Director of Consumer Technology and Service Development at Meridian Health, a not for profit health system in New Jersey that helped to create iMPak Health.

Frank Ille, CEO, of HealthSaaS said, "We are excited to announce this innovative alliance with iMPak because of the impact that it can make for elderly patients or others that are uncomfortable with computers, or who cannot afford expensive technology. Our collaboration with iMPak focusing on consistent monitoring of pain and medication adherence is an important aspect of any chronic pain management plan. This integrated solution can help improve clinical outcomes, reduce ER visits associated with over/under medicating and will decrease the overall costs associated with managing chronic pain."

"It is clear that both companies share a commitment to making it easy for the patient to engage in their own care," said Albert Baker Director at iMPak Health and VP of Strategic Relations at Cypak a Swedish based technology company that helped create iMPak Health. "A excellent patient experience is fundamental to providing excellent data for a effective outcome focused care system at large."

About HealthSaaS, Inc.
The HealthSaaS Connected Outcomes Platform is a cloud-based system designed to be interoperable with mHealth applications, cloud based services, Telehealth solutions and connected medical devices. This innovative Platform removes silo barriers and makes data available to clinician practices, provider networks, payers, self funded employers and EHR systems.

The HealthSaaS Connected Outcomes Platform is an FDA Class I Medical Device Data System. As an MDDS it is designed and developed in accordance with a quality system compliant with ISO13485 standards so it aligns with the quality requirements of U.S. and international regulatory agencies in the healthcare industry.

For more information, visit www.healthsaas.net


About iMPak Health, L.L.C.
A joint venture of Swedish-based chip developer and innovator Cypak and Meridian Health, a not for profit leader, iMPak Health brings together the latest in wireless technology and the frontline know-how of today's health care environment to provide consumers and patients with effective and intuitive tools to better manage their health.  IMPak Health's mission is to become a leader in developing, easy-to-use devices to screen, diagnose, and monitor health conditions.

For more information, visit www.impakhealth.com or follow us at @seimpakhealth.  



Media Contact: Frank Ille HealthSaaS, Inc., 503-459-9028, frank_ille@healthsaas.net

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE HealthSaaS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
Breaking Medicine News(10 mins):